PHA-543613

CAS No.

478149-53-0

MDL No.

N/A

C₁₅H₁₇N₃O₂

271.31

InChI Key

IPKZCLGGYKRDES-ZDUSSCGKSA-N

Pack Size	Purity	Price	Availability
5 mg	95%	$116	In Stock
10 mg	95%	$184	In Stock
25 mg	95%	$402	In Stock
50 mg	95%	$645	In Stock
100 mg	95%	$1027	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

5 mg

95%

$116

In Stock

10 mg

95%

$184

In Stock

25 mg

95%

$402

In Stock

50 mg

95%

$645

In Stock

100 mg

95%

$1027

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Pha-543613 is a phosphoramide and an organothiophosphorus compound.

CAS No.	478149-53-0
Product Name	PHA-543613

Biological Targets

CHRNA7

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Documentation

PHA-543613

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Related Articles

The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.

Alpha-7 nicotinic acetylcholine receptor (nAChR) agonist inhibits the development of endometriosis by regulating inflammation.

Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.

Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.

Documentation